Unveiling the Pharmacological Role of Human Deubiquitinating Enzymes in Temozolomide Response of Glioblastoma Cells
Cell Biochemistry and Biophysics · 2024
DOI: 10.1007/s12013-024-01325-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biochemistry and Biophysics, 2024. Verfasst von Chunguang Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Special Biomedicine; School of Medicine, Guangxi University, Nanning, Guangxi, 530004, China. Hauptthemen laut MEDLINE: Temozolomide, Glioblastoma, Deubiquitinating Enzymes, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: the Natural Science Foundation of Guangdong Province, Natural Science Foundation of Henan Province-Young Scientists Fund, Natural Science Research of Jiangsu Higher Education Institutions of China.
Abstract (Originalsprache)
Temozolomide (TMZ) stands as the primary chemotherapeutic drug utilized in clinical glioma treatment, particularly for high-grade glioblastoma (GBM). However, the emergence of TMZ resistance in GBM poses a significant hurdle to its clinical efficacy. Our objective was to elucidate the role of deubiquitinating enzymes (DUBs) in GBM cell resistance to TMZ. We employed the broad-spectrum DUBs inhibitor G5 to investigate the function of DUBs in TMZ cytotoxicity against GBM cells. Eighty-two GBM cell lines with specified DUBs knockout were generated and subjected to CCK-8 assays to assess cell proliferation and TMZ resistance. Furthermore, the association between DUBs and TMZ resistance in GBM cells, along with the modulation of autophagic flux, was examined. The pan-DUBs inhibitor G5 demonstrated the ability to induce cell death and enhance TMZ toxicity in GBM cells. Subsequently, we identified potential DUBs involved in regulating GBM cell proliferation and TMZ resistance. The impact of DUBs knockout on TMZ cytotoxicity was found to be associated with their regulation of TMZ-induced autophagy. In summary, our study provides primary insights into the role of DUBs in GBM cell proliferation and TMZ resistance, and contributes to a deeper understanding of the complex function of DUBs genes underlying TMZ resistance in GBM cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangxi Key Laboratory of Special Biomedicine; School of Medicine, Guangxi University, Nanning, Guangxi, 530004, China.
- Biotherapy Center, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510630, China.
- Department of Neurosurgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, 510630, China.
- Department of Neurosurgery, The First People's Hospital of Changzhou, Changzhou, Jiangsu, 213000, China.
- College of Life and Health Sciences, Guangdong Industry Polytechnic, Guangzhou, Guangdong, 510300, China.
- Precision Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450003, China. yizezhang007@163.com.
Förderung
- the Natural Science Foundation of Guangdong Province
- Natural Science Foundation of Henan Province-Young Scientists Fund
- Natural Science Research of Jiangsu Higher Education Institutions of China
- Changzhou High-Level Health Talents Training Project
Zitieren
APA
Yang, C., Li, Y., Wu, Q., Tang, J., Chen, M., Zhang, B., Li, B., Qin, Y., Huang, G., Zhang, Y., Zhi, F., & Liu, K. (2024). Unveiling the Pharmacological Role of Human Deubiquitinating Enzymes in Temozolomide Response of Glioblastoma Cells. Cell Biochemistry and Biophysics. https://doi.org/10.1007/s12013-024-01325-6
Vancouver
Yang C, Li Y, Wu Q, Tang J, Chen M, Zhang B, et al. Unveiling the Pharmacological Role of Human Deubiquitinating Enzymes in Temozolomide Response of Glioblastoma Cells. Cell Biochemistry and Biophysics. 2024. doi:10.1007/s12013-024-01325-6
BibTeX
@article{Yang2024,
author = {Yang, Chunguang and Li, Yifei and Wu, Qifan and Tang, Jiayi and Chen, Min and Zhang, Baoyu and Li, Bowen and Qin, Yunfei and Huang, Guobin and Zhang, Yize and Zhi, Feng and Liu, Kunpeng},
title = {Unveiling the Pharmacological Role of Human Deubiquitinating Enzymes in Temozolomide Response of Glioblastoma Cells},
journal = {Cell Biochemistry and Biophysics},
year = {2024},
doi = {10.1007/s12013-024-01325-6}
}
EUVIMED